Granules India Q2 profit jumps 39% to ₹181.8 crore

Drugmaker Granules India posted a 39% year-on-year rise in consolidated net profit to ₹181.8 crore for the September quarter, as revenue from operations grew 20% to ₹1,559.9 crore. EBITDA stood at ₹338 crore despite higher input and logistics costs linked to West Asia tensions. CMD Krishna Prasad Chigurupati said these cost pressures are likely to persist.